|
gptkb:Angiotensin_II
|
angiotensin receptor blockers (ARBs)
|
|
gptkb:AMP-activated_protein_kinase_(AMPK)
|
gptkb:mTOR_pathway
|
|
gptkb:NADH:ubiquinone_oxidoreductase_(complex_I)
|
gptkb:rotenone
|
|
gptkb:aldosterone
|
dopamine
|
|
gptkb:3C-like_protease
|
gptkb:nirmatrelvir
|
|
gptkb:checkpoint_kinase_2
|
small molecule inhibitors
|
|
gptkb:fatty_acid_synthase_(FASN)
|
gptkb:C75
|
|
gptkb:Angiotensin-converting_enzyme
|
treatment of chronic kidney disease
|
|
gptkb:phosphodiesterase_type_9
|
PF-04447943
|
|
gptkb:dopamine_transporter
|
gptkb:methylphenidate
|
|
gptkb:mouse_Hdac8
|
Suberoylanilide hydroxamic acid (SAHA)
|
|
gptkb:AMPK2
|
gptkb:ATP
|
|
gptkb:HCV_NS5B_polymerase
|
nucleoside analogs
|
|
gptkb:Caspase-8
|
gptkb:c-FLIP
|
|
gptkb:Mechanistic_target_of_rapamycin
|
gptkb:temsirolimus
|
|
gptkb:NS3/4A_serine_protease
|
asunaprevir
|
|
gptkb:protein_tyrosine_kinases
|
gptkb:entrectinib
|
|
gptkb:APEX1
|
CRT0044876
|
|
gptkb:human_ACHE_gene
|
gptkb:rivastigmine
|
|
gptkb:MEK4
|
JNJ-7706621
|